NASDAQ:AIKI AIkido Pharma (AIKI) Stock Price, News & Analysis → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free AIKI Stock Alerts $2.15 -0.03 (-1.38%) (As of 06/12/2024 ET) Add Compare Share Share Today's Range$2.15▼$2.1950-Day Range$2.05▼$2.9352-Week Range$3.31▼$11.48Volume4,868 shsAverage Volume79,326 shsMarket Capitalization$11.79 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends Get AIkido Pharma alerts: Email Address Ad Priority GoldBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. About AIkido Pharma Stock (NASDAQ:AIKI)AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.Read More AIKI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AIKI Stock News HeadlinesMarch 17, 2024 | seekingalpha.comSNOA Sonoma Pharmaceuticals, Inc.January 23, 2024 | wsj.comRoyalty Pharma PLCOctober 6, 2023 | msn.comKengan Ashura: 10 Strongest Fighters, RankedSeptember 6, 2023 | markets.businessinsider.comDominari Holdings Inc. Releases Shareholder UpdateApril 10, 2023 | markets.businessinsider.comKyle Wool Appears on Fox BusinessApril 3, 2023 | markets.businessinsider.comDominari Holdings Appoints George Way As CFOMarch 27, 2023 | markets.businessinsider.comDominari Financial Inc. Acquires Leading Broker Dealer and Registered Investment Advisor BusinessMarch 21, 2023 | benzinga.comDominari Financial Granted Approval to Acquire Broker DealerMarch 14, 2023 | finance.yahoo.comDominari Holdings Provides Business UpdateDecember 28, 2022 | finance.yahoo.comDominari Holdings Provides Update on Share Repurchase ProgramDecember 22, 2022 | finanznachrichten.deAIkido Pharma Inc.: AIkido Pharma Announces Successful Initial Public Offering of ASP IsotopesDecember 22, 2022 | finance.yahoo.comAIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)November 28, 2022 | finance.yahoo.comAIkido Pharma Announces Successful Initial Public Offering of ASP IsotopesOctober 6, 2022 | finance.yahoo.comAIkido Share Repurchase ContinuesOctober 5, 2022 | finance.yahoo.comAIkido Purchases More SharesOctober 4, 2022 | finance.yahoo.comShare Repurchase Program ContinuesOctober 3, 2022 | finance.yahoo.comAIkido Pharma Continues Share Repurchase ProgramSeptember 30, 2022 | finance.yahoo.comAIkido Pharma Provides Update on Share Repurchase ProgramSeptember 9, 2022 | prnewswire.comDominari Financial, Inc. Executes Definitive Agreement to Buy Broker-DealerAugust 10, 2022 | ca.investing.comPre-Open Movers: Nielsen Climbs 20%, AppLivin Makes Offer for UnityAugust 10, 2022 | marketwatch.comAIkido Pharma Gets $8/Share Buyout Offer From Shalom Auerbach >AIKIAugust 10, 2022 | nasdaq.comAIkido Pharma Receives Offer From Shalom Auerbach - Quick FactsAugust 10, 2022 | finance.yahoo.comAIkido Pharma Confirms Receipt of Unsolicited OfferAugust 9, 2022 | finance.yahoo.comInvestor Makes Proposal to Acquire AIkido Pharma for $8.00 Per Share in CashAugust 7, 2022 | reuters.comAikido Pharma IncSee More Headlines Receive AIKI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AIkido Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial physical research Sub-IndustryN/A Current SymbolNASDAQ:AIKI CUSIPN/A CIK12239 Webwww.spherix.com Phone(112) 745-1374Fax703-992-9348Employees4Year Founded1967Profitability EPS (Most Recent Fiscal Year)($3.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,170,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-18.21% Return on Assets-16.94% Debt Debt-to-Equity RatioN/A Current Ratio29.54 Quick Ratio29.54 Sales & Book Value Annual Sales$10,000.00 Price / Sales1,179.28 Cash FlowN/A Price / Cash FlowN/A Book Value$19.27 per share Price / Book0.11Miscellaneous Outstanding Shares5,485,000Free Float5,013,000Market Cap$11.79 million OptionableNot Optionable Beta0.93 Social Links 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Anthony C. Hayes Esq. (Age 54)CEO, Principal Financial Officer, Principal Accounting Officer & Director Comp: $960kMr. Darrell DotsonVP of Drug Devel. & Gen. CounselMr. Carlos AldaveroPres of Dominari FinancialKey CompetitorsXcel BrandsNASDAQ:XELBOneMedNetNASDAQ:ONMDbioAffinity TechnologiesNASDAQ:BIAFData Knights AcquisitionNASDAQ:DKDCAiSpecimenNASDAQ:ISPCView All Competitors AIKI Stock Analysis - Frequently Asked Questions How have AIKI shares performed in 2024? AIkido Pharma's stock was trading at $2.59 at the start of the year. Since then, AIKI shares have decreased by 17.0% and is now trading at $2.15. View the best growth stocks for 2024 here. When did AIkido Pharma's stock split? Shares of AIkido Pharma reverse split on Tuesday, June 7th 2022. The 1-17 reverse split was announced on Tuesday, June 7th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 7th 2022. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split. What other stocks do shareholders of AIkido Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other AIkido Pharma investors own include Biocept (BIOC), AIM ImmunoTech (AIM), Nuwellis (CHFS), Foresight Autonomous (FRSX), iBio (IBIO), Exela Technologies (XELA), Bionano Genomics (BNGO), Check-Cap (CHEK), Digital Ally (DGLY) and Purple Biotech (KTOV). How do I buy shares of AIkido Pharma? Shares of AIKI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does AIkido Pharma have any subsidiaries? The following companies are subsidiares of AIkido Pharma: Hoth Therapeutics.Read More This page (NASDAQ:AIKI) was last updated on 6/13/2024 by MarketBeat.com Staff From Our PartnersTrump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absoluteDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | SponsoredGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredWall Street Icon: "I'd Put 50% of My Kids' Inheritance in THIS stock"Wall Street Icon Warns: "A Great Financial Reset is Underway" The man CNBC called "The Prophet" predicted t...Stansberry Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.